High TGF-β2 levels during primary retinal detachment may protect against proliferative vitreoretinopathy

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 11, 2004, Pages 4113-4118

  Dieudonné, Suzanne C ^a   La Heij, Ellen C ^a   Diederen, Roselie ^a,b   Kessels, Alfons G H ^b   Liem, Albert T A ^a   Kijlstra, Aize ^a   Hendrikse, Fred ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA2; SCATTER FACTOR; TGFB2 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EYE PROTECTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA DETACHMENT; RISK ASSESSMENT; RISK FACTOR; SCLERA BUCKLING PROCEDURE; VITREORETINOPATHY; VITREOUS BODY; ADOLESCENT; BODY FLUID; ENZYME LINKED IMMUNOSORBENT ASSAY; EXUDATE; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; RECURRENT DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY FLUIDS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXUDATES AND TRANSUDATES; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RECURRENCE; RETINAL DETACHMENT; SCLERAL BUCKLING; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2; VITREORETINOPATHY, PROLIFERATIVE;

EID: 6944253466     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0643     Document Type: Article

References (32)

1. Kirchof B, Sorgent N. Pathogenesis of proliferative vitreoretinopathy. Proliferative vitreoretinopathy, genetics of glaucoma. Dev Ophthalmol (Basel). 1989;16:1-53.
2. Connor TB Jr, Roberts AB, Sporn MB, et al. Correlation of fibrosis and transforming growth factor-β type 2 levels in the eye. J Clin Invest. 1989;83:1661-1666.
3. Oshima Y, Sakamoto T, Hisatomi T, Tsutsumi C, Ueno H, Ishibashi T. Gene transfer of soluble TGF-beta type II receptor inhibits experimental proliferative vitreoretinopathy. Gene Ther. 2002;9: 1214-1220.
4. He PM, He S, Garner JA, Ryan SJ, Hinton DR. Retinal pigment epithelial cells secrete and respond to hepatocyte growth factor. Biochem Biophys Res Commun. 1998;249:253-257.
5. Lashkari K, Rahimi N, Kazlauskas A. Hepatocyte growth factor receptor in human RPE cells: implications in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1999;40:149-156.
6. Briggs MC, Grierson I, Hiscott P, Hunt JA. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease. Invest Ophthalmol Vis Sci. 2000;41:3085-3094.
7. Hinton DR, He S, Jin ML, Barron E, Ryan SJ. Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy. Eye. 2002;16:422-428.
8. Weidner KM, Arakaki N, Hartmann G, et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA. 1991;88:7001-7005.
9. Gonzalez-Avila G, Lozano D, Manjarrez ME, et al. Influence on collagen metabolism of vitreous from eyes with proliferative vitreoretinopathy. Ophthalmology. 1995;102:1400-1405.
10. Chen YS, Hackett SF, Schoenfeld CL, et al. Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes. Br J Ophthalmol. 1997;81:919-926.
11. Bochaton-Piallat ML, Kapetanios AD, Donati G, Redard M, Gabbiani G, Pournaras CJ. TGF-β1, TGF-β receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy. Invest Ophthalmol Vis Sci. 2000;41:2336-2342.
12. Esser P, Heimann K, Bartz-schmidt KU, et al. Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-β-induced RPE cell apoptosis. Exp Eye Res. 1997;65:365-378.
13. Kon CH, Occleston NL, Aylward GW, Khaw PT. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. Invest Ophthalmol Vis Sci. 1999;40:705-712.
14. La Heij EC, Van De Waarenburg MP, Blaauwgeers HG, et al. Levels of basic fibroblast growth factor, glutamine synthetase, and interleukin-6 in subretinal fluid from patients with retinal detachment. Am J Ophthalmol. 2001;132:544-550.
15. La Heij EC, Blaauwgeers HG, de Vente J, et al. Decreased levels of cGMP in vitreous and subretinal fluid from eyes with retinal detachment. Br J Ophthalmol. 2003:87:1409-1412.
16. Kon CH, Asaria RH, Occleston NL, Khaw PT, Aylward GW. Risk factors for proliferatiye vitreoretinopathy after primary vitrectomy: a prospective study. Br J Ophthalmol. 2000;84:506-511.
17. Retina Society Terminology Committee. The classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmology. 1983;90:121-125.
18. Sebag J, Tuyen W, Faure JP, Chauvaud D, Pouliquen Y. Retinal S-antigen in human subretinal fluid. Invest Ophthalmol Vis Sci. 1987;28:2038-2041.
19. Ferris FL III, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. 1982;94:91-96.
20. Limb GA, Little BC, Meager A, et al. Cytokines in proliferative vitreoretinopathy. Eye. 1991;5:686-693.
21. El Ghrably I, Powe DG, Orr G, et al. Apoptosis in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 2004;45:1473-1479.
22. Massague J. The transforming growth factor-β family. Annu Rev Cell Biol. 1990;6:597-641.
23. Guerin CJ, Hu L, Scicli G, Scicli AG. Transforming growth factor beta in experimentally detached retina and periretinal membranes. Exp Eye Res. 2001;73:753-764.
24. Leschey KH, Hackett SF, Singer JH, Campochiaro PA. Growth factor responsiveness of human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1990;31:839-846.
25. Lee SC, Kwon OW, Seong GJ, Kim SH, Ahn JE, Kay ED. Epitheliomesenchymal transdifferentiation of cultured RPE cells. Ophthalmic Res. 2001;33:80-86.
26. Hiscott PS, Grierson I, McLeod D. Natural history of fibrocellular epiretinal membranes: a quantitative, autoradiographic, and immunohistochemical study. Br J Ophthalmol. 1985;69:810-823.
27. Weller M, Esser P, Heimann K, Wiedemann P. Retinal microglia: a new cell in idiopathic proliferative vitreoretinopathy? Exp Eye Res. 1991;53:275-281.
28. Esser P, Heimann K, Wiedemann P. Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy. differentiation of subpopulations. Br J Ophthalmol. 1993;77:731-733.
29. Anderson DH, Guerin CJ, Hageman GS, Pfeffer BA, Flanders KC. Distribution of transforming growth factor-β isoforms in the mammalian retina. J Neurosci Res. 1995;42:63-79.
30. Kauffmann DJ, van Meurs JC, Mertens DA, Peperkamp E, Master C, Gerritsen ME. Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1994;35:900-906.
31. La Heij EC, van de Waarenburg MP, Blaauwgeers HG, et al. Basic fibroblast growth factor, glutamine synthetase, and interleukin-6 in vitreous fluid from eyes with retinal detachment complicated by proliferative vitreoretinopathy. Am J Ophthalmol. 2002;134:367-375.
32. Jin M, Chen Y, He S, Ryan SJ, Hinton DR. Hepatocyte growth factor and its role in the pathogenesis of retinal detachment. Invest Ophthalmol Vis Sci. 2004;45:323-329.